{"id":18547,"date":"2019-05-17T11:07:54","date_gmt":"2019-05-17T09:07:54","guid":{"rendered":"https:\/\/fundaciongaem.org\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/"},"modified":"2019-05-17T11:07:54","modified_gmt":"2019-05-17T09:07:54","slug":"bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2","status":"publish","type":"post","link":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/","title":{"rendered":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector"},"content":{"rendered":"<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<h3>Bionure llan\u00e7a una\u00a0campanya de<em> crowdfunding\u00a0<\/em>per posar en marxa l&#8217;estudi cl\u00ednic de Fase 2 del seu neuroprotector BN201<\/h3>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>El compost acaba de completar amb \u00e8xit l&#8217;assaig de Fase 1 en humans<\/strong><\/li>\n<li><strong>La companyia biotecnol\u00f2gica refor\u00e7a el seu equip amb el nomenament de la Dra. Luc\u00eda Septi\u00e9n-V\u00e9lez com a directora m\u00e8dica<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/bionure.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Bionure<\/a>, biotecnol\u00f2gica especialitzada en neuroprotecci\u00f3 que t\u00e9 la seu al Parc Cient\u00edfic de Barcelona (PCB), obre avui la <strong>campanya de <em>crowdfunding<\/em>\u00a0<a href=\"https:\/\/capitalcell.es\/campaign\/bionure-2019\/\" target=\"_blank\" rel=\"noopener noreferrer\">M\u00faltiples Motivos<\/a><\/strong>\u00a0a la plataforma de Capital Cell, amb l&#8217;objectiu de captar 1,3 milions d&#8217;euros per finan\u00e7ar la preparaci\u00f3 de l&#8217;assaig cl\u00ednic de Fase 2 del seu compost <strong>neuroprotector BN201.<\/strong><\/p>\n<p>El BN201, que ha completat amb \u00e8xit l&#8217;estudi de Fase 1 de seguretat, tolerabilitat i farmacocin\u00e8tica en voluntaris sans, que va concloure al gener al Regne Unit, ha demostrat al laboratori amb models animals que \u00e9s capa\u00e7 de protegir els axons i promoure la remielinitzaci\u00f3 de neurones danyades, el que el converteix en un candidat \u00f2ptim per tractar malalties neurodegeneratives com l&#8217;esclerosi m\u00faltiple (EM).<\/p>\n<p>&nbsp;<\/p>\n<p>Bionure centra els seus esfor\u00e7os actualment en l&#8217;esclerosi m\u00faltiple i en la neuritis \u00f2ptica aguda (NOA), una malaltia oftalmol\u00f2gica rara que en un 30% dels casos es revela com a s\u00edmptoma d&#8217;hora de l&#8217;EM, i per la qual el BN201 compta amb una designaci\u00f3 de medicament orfe a Europa i Estats Units. Els tractaments disponibles per EM i NOA es basen en medicaments antiinflamatoris o immunomoduladors, que redueixen la inflamaci\u00f3 per\u00f2 que no reparen les lesions que han patit les neurones ni les protegeixen prou.<\/p>\n<blockquote><p>&#8220;El nostre objectiu \u00e9s posar en marxa la Fase 2 a principis de 2020 amb pacients que hagin patit episodis de neuritis \u00f2ptica per provar l&#8217;efic\u00e0cia del BN201 com a neuroprotector i inductor de la remielinitzaci\u00f3 dels neurones. Els fons captats en aquesta campanya ens permetran completar els preparatius regulatoris i t\u00e8cnics de l&#8217;assaig en els pr\u00f2xims mesos &#8220;, explica Lauren Nguyen, CEO de Bionure.<\/p><\/blockquote>\n<p>&nbsp;<\/p>\n<p>La companyia, que forma part de l&#8217;<a href=\"https:\/\/fundaciongaem.org\/ca\/innovacio\/\" target=\"_blank\" rel=\"noopener noreferrer\">Acceleradora de la Fundaci\u00f3 GAEM<\/a> -una de les associacions de pacients d&#8217;EM m\u00e9s compromeses amb la\u00a0recerca- preveu que els assajos de Fase 2 es completaran el 2022 i anticipa que, si aquests confirmen els resultats de les proves precl\u00edniques la valoraci\u00f3 de la companyia es multiplicar\u00e0 per set, permetent una sortida molt rendible per als petits inversors que ho desitgin. Bionure va captar 1,2 milions d&#8217;euros en una anterior campanya de crowfunding, portada a terme el 2017, que va destinar a dur a terme la Fase 1 que acaba de completar-se.<\/p>\n<p>&nbsp;<\/p>\n<p>El mecanisme d&#8217;acci\u00f3 del BN201 pot permetre usar-lo en el futur per a altres indicacions que poden beneficiar-se de la seva capacitat neuroprotectora, com altres trastorns neurodegeneratius, malalties cerebrovasculars, algunes patologies oftalmol\u00f2giques i lesions traum\u00e0tiques del sistema nervi\u00f3s central.<\/p>\n<blockquote><p>&#8220;El potencial del BN201 \u00e9s enorme i \u00e9s probable que les pr\u00f2ximes rondes de finan\u00e7ament es realitzin amb inversors institucionals, de manera que la Fase 2 marca un punt d&#8217;inflexi\u00f3 que converteix aquesta campanya de crowdfunding en l&#8217;\u00faltima oportunitat per a petits i mitjans inversors de participar en el projecte &#8220;, subratlla el CEO de Bionure.<\/p><\/blockquote>\n<p>Els medicaments per al sistema nervi\u00f3s central representen una part substancial del mercat de f\u00e0rmacs de prescripci\u00f3, amb unes vendes anuals que superen els 50.000 milions de d\u00f2lars, dels quals un 40% (20.000 milions de d\u00f2lars) s\u00f3n de f\u00e0rmacs per tractar l&#8217;esclerosi m\u00faltiple.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Refor\u00e7 de l&#8217;equip<\/strong><\/p>\n<p>Per afrontar amb \u00e8xit aquest moment clau per a la companyia, amb la posada en marxa de la Fase 2, Bionure ha refor\u00e7at el seu equip amb la incorporaci\u00f3 de la Dra. Ll\u00facia Septi\u00e9n-V\u00e9lez com a nova directora m\u00e8dica (CMO).<\/p>\n<p>La Dra. Septi\u00e9n va desenvolupar una s\u00f2lida traject\u00f2ria com a metge en neurologia i psiquiatria i, posteriorment, va acumular una llarga experi\u00e8ncia en desenvolupament de medicaments i assumptes regulatoris. Abans d&#8217;incorporar-se Bionure, havia ocupat diversos llocs de responsabilitat en l&#8217;\u00e0mbit m\u00e8dic i regulatori amb el focus en neuroci\u00e8ncies en grans companyies farmac\u00e8utiques com Pfizer, Wyeth, GSK, Servier i Ipsen, i va treballar tamb\u00e9 en el sector &#8216;biotec&#8217; com a directora m\u00e8dica en DBV Technologies.<\/p>\n<p><em>&#8220;Donem una calorosa benvinguda a Luc\u00eda. La seva sensibilitat amb els pacients, la seva experi\u00e8ncia en el desenvolupament de f\u00e0rmacs per al sistema nervi\u00f3s i els seus dots de lideratge v\u00e9nen a refor\u00e7ar l&#8217;equip de Bionure&#8221;<\/em>, ha manifestat Laurent Nguyen. <em>&#8220;Estem conven\u00e7uts de la seva capacitat per portar endavant els nostres projectes en nueroprotecci\u00f3&#8221;.<\/em><\/p>\n<p><em>&#8220;En la meva pr\u00e0ctica com a metge i en el desenvolupament de f\u00e0rmacs, m&#8217;he trobat amb molts pacients desesperats per la progressi\u00f3 de les seves malalties neurodegeneratives&#8221;<\/em>, comenta la Dra. Septi\u00e9n. <em>&#8220;Estic entusiasmada d&#8217;unir-me a un equip comprom\u00e8s amb canviar el curs de malalties que condueixen a la discapacitat.&#8221;<\/em><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<hr \/>\n<\/div>\n<div class=\"page\" title=\"Page 2\"><\/div>\n<p><strong>Informaci\u00f3 relacionada:<\/strong><\/p>\n<p><a href=\"https:\/\/fundaciongaem.org\/ca\/gaem-multiples-motivos-bionure\/\" target=\"_blank\" rel=\"noopener noreferrer\">Fundaci\u00f3 GAEM participa a la trobada informativa de Bionure \u2013 22 de maig<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Not\u00edcia relacionada:<\/strong><\/p>\n<p><a href=\"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2019\/05\/20190507_Bionure-supera-la-fase-I-y-prepara-una-ronda-puente_Expansion-Catalu%C3%B1a-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Bionure supera la fase I y prepara una ronda puente<\/a>_Expansi\u00f3n<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bionure llan\u00e7a la campanya de crowdfunding &#8220;M\u00faltiples Motivos&#8221; amb l&#8217;objectiu de captar 1,3 milions d&#8217;euros per posar en marxa l&#8217;estudi cl\u00ednic de Fase 2 del seu neuroprotector BN201. El compost ha completat amb \u00e8xit l&#8217;estudi cl\u00ednic de Fase 1 de seguretat, tolerabilitat i farmacocin\u00e8tica, i ha demostrat en models animals que \u00e9s capa\u00e7 de protegir els axons i promoure la remielinitzaci\u00f3, el que el converteix en un candidat \u00f2ptim per tractar malalties neurodegeneratives com l&#8217;esclerosi m\u00faltiple.<\/p>\n","protected":false},"author":1,"featured_media":17783,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[212],"tags":[1768,1769,1801,1541,1594,1595,1802,1771,1989],"class_list":["post-18547","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-em-i-nmo","tag-bionure","tag-bn201","tag-crowdfunding","tag-esclerosi-multiple","tag-fundacio-gaem","tag-investigacio-biomedica","tag-multiples-motivos","tag-neuroprotector","tag-tractaments-esclerosi-multiple","category-212","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\" \/>\n<meta property=\"og:description\" content=\"Bionure llan\u00e7a la campanya de crowdfunding &quot;M\u00faltiples Motivos&quot; amb l&#039;objectiu de captar 1,3 milions d&#039;euros per posar en marxa l&#039;estudi cl\u00ednic de Fase 2 del seu neuroprotector BN201. El compost ha completat amb \u00e8xit l&#039;estudi cl\u00ednic de Fase 1 de seguretat, tolerabilitat i farmacocin\u00e8tica, i ha demostrat en models animals que \u00e9s capa\u00e7 de protegir els axons i promoure la remielinitzaci\u00f3, el que el converteix en un candidat \u00f2ptim per tractar malalties neurodegeneratives com l&#039;esclerosi m\u00faltiple.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/\" \/>\n<meta property=\"og:site_name\" content=\"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FundacioGaem\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-17T09:07:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png\" \/>\n\t<meta property=\"og:image:width\" content=\"691\" \/>\n\t<meta property=\"og:image:height\" content=\"466\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"PROGRAMADOR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@fundaciongaem\" \/>\n<meta name=\"twitter:site\" content=\"@fundaciongaem\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"PROGRAMADOR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/\"},\"author\":{\"name\":\"PROGRAMADOR\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#\\\/schema\\\/person\\\/093d963705cb588ce96ffe4a15bde10c\"},\"headline\":\"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector\",\"datePublished\":\"2019-05-17T09:07:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/\"},\"wordCount\":887,\"publisher\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png\",\"keywords\":[\"Bionure\",\"BN201\",\"Crowdfunding\",\"Esclerosi M\u00faltiple\",\"Fundaci\u00f3 GAEM\",\"Investigaci\u00f3 biom\u00e8dica\",\"M\u00faltiples Motivos\",\"neuroprotector\",\"tractaments esclerosi m\u00faltiple\"],\"articleSection\":[\"EM \\\/ NMO\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/\",\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/\",\"name\":\"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png\",\"datePublished\":\"2019-05-17T09:07:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png\",\"contentUrl\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png\",\"width\":691,\"height\":466},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/\",\"name\":\"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#organization\",\"name\":\"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\",\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/LOGO-2.png\",\"contentUrl\":\"https:\\\/\\\/fundaciongaem.org\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/LOGO-2.png\",\"width\":354,\"height\":132,\"caption\":\"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)\"},\"image\":{\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FundacioGaem\\\/\",\"https:\\\/\\\/x.com\\\/fundaciongaem\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/2454646\",\"https:\\\/\\\/www.instagram.com\\\/fundaciongaem\\\/cebook.com\\\/FundacioGaem\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/fundaciogaem\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/#\\\/schema\\\/person\\\/093d963705cb588ce96ffe4a15bde10c\",\"name\":\"PROGRAMADOR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g\",\"caption\":\"PROGRAMADOR\"},\"sameAs\":[\"https:\\\/\\\/fundaciongaem.org\"],\"url\":\"https:\\\/\\\/fundaciongaem.org\\\/ca\\\/author\\\/gaem\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","og_description":"Bionure llan\u00e7a la campanya de crowdfunding \"M\u00faltiples Motivos\" amb l'objectiu de captar 1,3 milions d'euros per posar en marxa l'estudi cl\u00ednic de Fase 2 del seu neuroprotector BN201. El compost ha completat amb \u00e8xit l'estudi cl\u00ednic de Fase 1 de seguretat, tolerabilitat i farmacocin\u00e8tica, i ha demostrat en models animals que \u00e9s capa\u00e7 de protegir els axons i promoure la remielinitzaci\u00f3, el que el converteix en un candidat \u00f2ptim per tractar malalties neurodegeneratives com l'esclerosi m\u00faltiple.","og_url":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/","og_site_name":"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","article_publisher":"https:\/\/www.facebook.com\/FundacioGaem\/","article_published_time":"2019-05-17T09:07:54+00:00","og_image":[{"width":691,"height":466,"url":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png","type":"image\/png"}],"author":"PROGRAMADOR","twitter_card":"summary_large_image","twitter_creator":"@fundaciongaem","twitter_site":"@fundaciongaem","twitter_misc":{"Escrit per":"PROGRAMADOR","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#article","isPartOf":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/"},"author":{"name":"PROGRAMADOR","@id":"https:\/\/fundaciongaem.org\/ca\/#\/schema\/person\/093d963705cb588ce96ffe4a15bde10c"},"headline":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector","datePublished":"2019-05-17T09:07:54+00:00","mainEntityOfPage":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/"},"wordCount":887,"publisher":{"@id":"https:\/\/fundaciongaem.org\/ca\/#organization"},"image":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#primaryimage"},"thumbnailUrl":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png","keywords":["Bionure","BN201","Crowdfunding","Esclerosi M\u00faltiple","Fundaci\u00f3 GAEM","Investigaci\u00f3 biom\u00e8dica","M\u00faltiples Motivos","neuroprotector","tractaments esclerosi m\u00faltiple"],"articleSection":["EM \/ NMO"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/","url":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/","name":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector - GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","isPartOf":{"@id":"https:\/\/fundaciongaem.org\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#primaryimage"},"image":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#primaryimage"},"thumbnailUrl":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png","datePublished":"2019-05-17T09:07:54+00:00","breadcrumb":{"@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#primaryimage","url":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png","contentUrl":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2024\/03\/Captura-de-pantalla-2019-05-17-a-las-13.05.51.png","width":691,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/fundaciongaem.org\/ca\/bionure-obre-un-crowdfunding-per-passar-a-fase-2-amb-el-seu-neuroprotector-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fundaciongaem.org\/ca\/inicio\/"},{"@type":"ListItem","position":2,"name":"Bionure obre un crowdfunding per passar a fase 2 amb el seu neuroprotector"}]},{"@type":"WebSite","@id":"https:\/\/fundaciongaem.org\/ca\/#website","url":"https:\/\/fundaciongaem.org\/ca\/","name":"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","description":"","publisher":{"@id":"https:\/\/fundaciongaem.org\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fundaciongaem.org\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/fundaciongaem.org\/ca\/#organization","name":"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)","url":"https:\/\/fundaciongaem.org\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fundaciongaem.org\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2023\/11\/LOGO-2.png","contentUrl":"https:\/\/fundaciongaem.org\/wp-content\/uploads\/2023\/11\/LOGO-2.png","width":354,"height":132,"caption":"GAEM (Grupo de Afectados de Esclerosis M\u00faltiple)"},"image":{"@id":"https:\/\/fundaciongaem.org\/ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FundacioGaem\/","https:\/\/x.com\/fundaciongaem","https:\/\/www.linkedin.com\/company\/2454646","https:\/\/www.instagram.com\/fundaciongaem\/cebook.com\/FundacioGaem\/","https:\/\/www.youtube.com\/user\/fundaciogaem"]},{"@type":"Person","@id":"https:\/\/fundaciongaem.org\/ca\/#\/schema\/person\/093d963705cb588ce96ffe4a15bde10c","name":"PROGRAMADOR","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b57ee1544b5750bf1116758aec83af4d7c9709bbc2131c9e1568d92ff8d2e28b?s=96&d=mm&r=g","caption":"PROGRAMADOR"},"sameAs":["https:\/\/fundaciongaem.org"],"url":"https:\/\/fundaciongaem.org\/ca\/author\/gaem\/"}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/posts\/18547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/comments?post=18547"}],"version-history":[{"count":0,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/posts\/18547\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/media\/17783"}],"wp:attachment":[{"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/media?parent=18547"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/categories?post=18547"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fundaciongaem.org\/ca\/wp-json\/wp\/v2\/tags?post=18547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}